DE602005020796D1 - Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin - Google Patents

Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin

Info

Publication number
DE602005020796D1
DE602005020796D1 DE602005020796T DE602005020796T DE602005020796D1 DE 602005020796 D1 DE602005020796 D1 DE 602005020796D1 DE 602005020796 T DE602005020796 T DE 602005020796T DE 602005020796 T DE602005020796 T DE 602005020796T DE 602005020796 D1 DE602005020796 D1 DE 602005020796D1
Authority
DE
Germany
Prior art keywords
formulation
taste
soluble cyclodextrin
cyclodextrin
quickly soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005020796T
Other languages
English (en)
Inventor
Jennifer Hsing-Chung Chu
Dwayne Thomas Friesen
David Keith Lyon
Rodney James Ketner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bend Research Inc
Original Assignee
Bend Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bend Research Inc filed Critical Bend Research Inc
Publication of DE602005020796D1 publication Critical patent/DE602005020796D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
DE602005020796T 2004-07-22 2005-07-11 Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin Active DE602005020796D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59080304P 2004-07-22 2004-07-22
PCT/IB2005/002231 WO2006011051A1 (en) 2004-07-22 2005-07-11 Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form

Publications (1)

Publication Number Publication Date
DE602005020796D1 true DE602005020796D1 (de) 2010-06-02

Family

ID=35094144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020796T Active DE602005020796D1 (de) 2004-07-22 2005-07-11 Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin

Country Status (9)

Country Link
US (1) US20080075784A1 (de)
EP (1) EP1771161B1 (de)
JP (1) JP2008507504A (de)
AT (1) ATE464883T1 (de)
BR (1) BRPI0513455A (de)
CA (1) CA2574602A1 (de)
DE (1) DE602005020796D1 (de)
MX (1) MX2007000759A (de)
WO (1) WO2006011051A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
HUE042304T2 (hu) 2004-04-23 2019-06-28 Cydex Pharmaceuticals Inc DPI készítmény, amely szulfoalkil-éter-ciklodextrint tartalmaz
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
JP5465432B2 (ja) 2005-10-26 2014-04-09 サイデックス・ファーマシューティカルズ・インコーポレイテッド スルホアルキルエーテルシクロデキストリン組成物及びその製造方法
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20090239942A1 (en) * 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
JP2009091309A (ja) * 2007-10-10 2009-04-30 Japan Organo Co Ltd バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品
JPWO2009054432A1 (ja) * 2007-10-26 2011-03-03 第一三共株式会社 口腔内速崩壊性医薬組成物およびその製造方法
US20100286154A1 (en) * 2007-11-15 2010-11-11 Susanne Christine Wieland-Berghausen Antihelmintic paste
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
PT2346509T (pt) 2008-10-07 2020-08-05 Horizon Orphan Llc Inalação de levofloxacina para redução da inflamação pulmonar
PL2344129T3 (pl) 2008-10-07 2018-07-31 Horizon Orphan Llc Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych
FR2936952A1 (fr) * 2008-10-09 2010-04-16 Monique Bellec Administration par voie orale de medicaments et complements nutritionnels
US20100273822A1 (en) * 2009-04-22 2010-10-28 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
US8545892B2 (en) 2009-06-26 2013-10-01 Nano Pharmaceutical Laboratories, Llc Sustained release beads and suspensions including the same for sustained delivery of active ingredients
US8518448B2 (en) * 2009-06-26 2013-08-27 Robert Niichel Sustained release beads and suspensions including the same for sustained delivery of active ingredients
AU2010289326B2 (en) 2009-09-04 2015-09-24 Horizon Therapeutics U.S. Holding Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US8187617B2 (en) * 2009-09-11 2012-05-29 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
WO2011110939A2 (en) 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
RU2013116336A (ru) 2010-09-13 2014-10-20 Бев-Арэкс, Инк. Водная система доставки лекарств, содержащая маскирующий вкус агент
AU2015377223A1 (en) 2015-01-12 2017-08-31 Nano Pharmaceutical Laboratories Llc Layered sustained-release microbeads and methods of making the same
CN107288680A (zh) * 2017-07-03 2017-10-24 安徽天顺环保设备股份有限公司 一种矿用泡沫除尘剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
EP0640344B1 (de) * 1993-08-30 1998-10-07 Medichemie Ag Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
ATE438305T1 (de) * 1998-03-23 2009-08-15 Gen Mills Inc Verkapselung von komponenten in essbaren produkten
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US20030148996A1 (en) * 2000-03-31 2003-08-07 Joseph Rubinfeld Camptothecin complexes
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20050038039A1 (en) * 2002-01-15 2005-02-17 Domenico Fanara Formulations
JP2005526104A (ja) * 2002-04-04 2005-09-02 ファイザー・プロダクツ・インク 味の良い咀嚼可能な錠剤

Also Published As

Publication number Publication date
WO2006011051A1 (en) 2006-02-02
ATE464883T1 (de) 2010-05-15
US20080075784A1 (en) 2008-03-27
BRPI0513455A (pt) 2008-05-06
EP1771161A1 (de) 2007-04-11
JP2008507504A (ja) 2008-03-13
CA2574602A1 (en) 2006-02-02
EP1771161B1 (de) 2010-04-21
MX2007000759A (es) 2007-03-28

Similar Documents

Publication Publication Date Title
DE602005020796D1 (de) Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
BRPI0518266A2 (pt) medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular
WO2006058249A3 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
NZ588913A (en) Liver cancer drug
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
WO2007107305A3 (en) Treatment of triple receptor negative breast cancer
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
TW200626158A (en) Naphthaline derivatives
WO2006129318A3 (en) Benzofuran derivatives with therapeutic activities
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
WO2005035485A3 (en) Analgesic compounds, their synthesis and pharmaceutical compositions containing them
DK1173176T3 (da) Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas
ATE410152T1 (de) Therapeutisches system mit amoxicillin und clavulansäure
BRPI0407679A (pt) sulfamatos de estra-1,3,5(10)-trien-3-ila 2-substituìdos ativos antitumor
CA2385755A1 (en) Prevention of colorectal cancer
PT1156805E (pt) Utilizacao de sistenas piliciclicos de tiazole para a fabricacao de medicamentospara a profilaxia ou o tratamento de obesidade
HN2003000104A (es) Derivados de ciclopenteno
ATE556062T1 (de) 3,4-dihydrochinazolinderivate
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
AU2003281468A1 (en) P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient

Legal Events

Date Code Title Description
8364 No opposition during term of opposition